Vulnerability · CVE-2025-43741
A reflected cross-site scripting (XSS) vulnerability in the Liferay Portal 7.4.0 through 7.4.3.132, and Liferay DXP 2025.Q1.0 through 2025.Q1.3, 2024.Q4.0 through 2024.Q4.7, 2024.Q
Published Aug 20, 2025 · catalog updated Aug 20, 2025 · Liferay DXP
Check if you run it
No confirmed exploitation is on record for CVE-2025-43741. EPSS is 0.22%. Act only if a listed version of Liferay DXP is installed.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium5.1
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.22%
- Remediation
- Advisory link
- Affected products
- vendor Liferay DXP 2025.Q1.0 ≤2025.Q1.3
A reflected cross-site scripting (XSS) vulnerability in the Liferay Portal 7.4.0 through 7.4.3.132, and Liferay DXP 2025.Q1.0 through 2025.Q1.3, 2024.Q4.0 through 2024.Q4.7, 2024.Q3.1 through 2024.Q3.13, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.14 and 7.4 GA through update 92 allows an remote authenticated attacker to inject JavaScrip in the _com_liferay_users_admin_web_portlet_UsersAdminPortlet_assetTagNames parameter
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor Liferay DXP 2025.Q1.0 ≤2025.Q1.32025.Q1.0 ≤2025.Q1.3
How to fix CVE-2025-43741
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2025-43741. EPSS is 0.22%. Act only if a listed version of Liferay DXP is installed.
Which versions are affected?
Compare what you have installed with Liferay DXP 2025.Q1.0 ≤2025.Q1.3 2025.Q1.0 ≤2025.Q1.3. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 0.22%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Aug 20, 2025 · EUVD
Detected
A reflected cross-site scripting (XSS) vulnerability in the Liferay Portal 7.4.0 through 7.4.3.132, and Liferay DXP 2025.Q1.0 through 2025.Q1.3, 2024.Q4.0 through 2024.Q4.7, 2024.Q3.1 through 2024.Q3.13, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.14 and 7.4 GA through update 92 allows an remote authenticated attacker to inject JavaScrip in the _com_liferay_users_admin_web_portlet_User
Aug 20, 2025 · EUVD
Updated
A reflected cross-site scripting (XSS) vulnerability in the Liferay Portal 7.4.0 through 7.4.3.132, and Liferay DXP 2025.Q1.0 through 2025.Q1.3, 2024.Q4.0 through 2024.Q4.7, 2024.Q3.1 through 2024.Q3.13, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.14 and 7.4 GA through update 92 allows an remote authenticated attacker to inject JavaScrip in the _com_liferay_users_admin_web_portlet_User
Sources
- CVE.orgVulnerability recordCVE-2025-43741
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2025-43741
30-day exploitation probability 0.22%
first.org - EUVDVulnerability recordEUVD-2025-25271
A reflected cross-site scripting (XSS) vulnerability in the Liferay Portal 7.4.0 through 7.4.3.132, and Liferay DXP 2025.Q1.0 through 2025.Q1.3, 2024.Q4.0 through 2024.Q4.7, 2024.Q3.1 through 2024.Q3.13, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.14 and 7.4 GA throug
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Oct 23, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.